Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ovarian Neoplasms

  Free Subscription


23.12.2018

2 BMC Cancer
2 Cancer Res
1 Clin Cancer Res
3 Gynecol Oncol
1 Hum Pathol
1 Int J Cancer
2 Int J Gynaecol Obstet
1 Oncogene
1 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. BAI Y, Li LD, Li J, Lu X, et al
    Prognostic values of S100 family members in ovarian cancer patients.
    BMC Cancer. 2018;18:1256.
    PubMed     Text format     Abstract available

  2. CONTEDUCA V, Gurioli G, Rossi L, Scarpi E, et al
    Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.
    BMC Cancer. 2018;18:1267.
    PubMed     Text format     Abstract available


    Cancer Res

  3. HOODA J, Novak M, Salomon MP, Matsuba C, et al
    Early loss of Histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer.
    Cancer Res. 2018 Dec 18. pii: 0008-5472.CAN-18-2297.
    PubMed     Text format     Abstract available

  4. YANG Y, Wu L, Shu X, Lu Y, et al
    Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk.
    Cancer Res. 2018 Dec 17. pii: 0008-5472.CAN-18-2726.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. BLAGDEN SP, Hamilton AL, Mileshkin L, Wong S, et al
    Phase IB Dose-Escalation and Expansion Study of AKT kinase inhibitor Afuresertib with Carboplatin and Paclitaxel in Recurrent Platinum-Resistant Ovarian Cancer.
    Clin Cancer Res. 2018 Dec 18. pii: 1078-0432.CCR-18-2277.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  6. NIE D, Gong H, Mao X, Li Z, et al
    Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: A retrospective study.
    Gynecol Oncol. 2018 Dec 14. pii: S0090-8258(18)31454.
    PubMed     Text format     Abstract available

  7. DAVIDSON BA, Broadwater G, Crim A, Boccacio R, et al
    Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
    Gynecol Oncol. 2018 Dec 14. pii: S0090-8258(18)31475.
    PubMed     Text format     Abstract available

  8. RODRIGUEZ-FREIXINOS V, Farinas-Madrid L, Gil-Martin M, Barretina-Ginesta P, et al
    Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients.
    Gynecol Oncol. 2018 Dec 12. pii: S0090-8258(18)31456.
    PubMed     Text format     Abstract available


    Hum Pathol

  9. ESPINOSA I, D'Angelo E, Corominas M, Gonzalez A, et al
    Mixed Endometrial Carcinomas with a "Low-Grade Serous"-Like Component: a Clinicopathologic, Immunohistochemical, and Molecular Genetic Study.
    Hum Pathol. 2017 Oct 24. pii: S0046-8177(17)30385.
    PubMed     Text format     Abstract available


    Int J Cancer

  10. FORTNER RT, Poole EM, Wentzensen NA, Trabert B, et al
    Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium.
    Int J Cancer. 2018 Dec 18. doi: 10.1002/ijc.32075.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  11. BASU P, Mukhopadhyay A, Konishi I
    Targeted therapy for gynecologic cancers: Toward the era of precision medicine.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:131-136.
    PubMed     Text format     Abstract available

  12. BEREK JS, Kehoe ST, Kumar L, Friedlander M, et al
    Cancer of the ovary, fallopian tube, and peritoneum.
    Int J Gynaecol Obstet. 2018;143 Suppl 2:59-78.
    PubMed     Text format     Abstract available


    Oncogene

  13. MOTOHARA T, Masuda K, Morotti M, Zheng Y, et al
    An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment.
    Oncogene. 2018 Dec 19. pii: 10.1038/s41388-018-0637.
    PubMed     Text format     Abstract available


    Oncol Rep

  14. WANG W, Wang J, Yan H, Zhang K, et al
    Upregulation of USP11 promotes epithelialtomesenchymal transition by deubiquitinating Snail in ovarian cancer.
    Oncol Rep. 2018 Dec 12. doi: 10.3892/or.2018.6924.
    PubMed     Text format     Abstract available


    PLoS One

  15. YODSURANG V, Tang Y, Takahashi Y, Tanikawa C, et al
    Genome-wide association study (GWAS) of ovarian cancer in Japanese predicted regulatory variants in 22q13.1.
    PLoS One. 2018;13:e0209096.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: